Encompass Health Corporation Proceeds from Sale of Restricted Investments
Encompass Health Corporation (EHC) reported Proceeds from Sale of Restricted Investments of $59.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfRestrictedInvestments · last filed 2026-08-07
- Encompass Health Corporation proceeds from sale of restricted investments for the quarter ending 2026-06-30 was $16.70M, a 86.20% decline year-over-year.
- Encompass Health Corporation proceeds from sale of restricted investments for the quarter ending 2026-03-31 was $42.90M, a 290.00% increase year-over-year.
- Encompass Health Corporation proceeds from sale of restricted investments for the quarter ending 2025-12-31 was $12.80M, a 1180.00% increase year-over-year.
- Encompass Health Corporation proceeds from sale of restricted investments for the quarter ending 2025-09-30 was $28.00M, a 3011.11% increase year-over-year.
- Encompass Health Corporation proceeds from sale of restricted investments for fiscal 2025 was $172.80M, a 814.29% increase from fiscal 2024.
- Encompass Health Corporation proceeds from sale of restricted investments for fiscal 2024 was $18.90M, a 155.41% increase from fiscal 2023.
- Encompass Health Corporation proceeds from sale of restricted investments for fiscal 2023 was $7.40M.
- Encompass Health Corporation proceeds from sale of restricted investments for fiscal 2022 was $0.00.
| Period end | Proceeds from Sale of Restricted Investments 3 month | Proceeds from Sale of Restricted Investments 6 month | Proceeds from Sale of Restricted Investments 9 month | Proceeds from Sale of Restricted Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $59.60M 10-Q · filed 2026-08-07 | $72.40M derived: sum of 3 quarters · filed 2026-08-07 | $100.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $42.90M 10-Q · filed 2026-05-01 | $55.70M derived: sum of 2 quarters · filed 2026-05-01 | $83.70M derived: sum of 3 quarters · filed 2026-05-01 | $204.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $40.80M derived: sum of 2 quarters · filed 2026-02-26 | $161.80M derived: sum of 3 quarters · filed 2026-08-07 | $172.80M 10-K · filed 2026-02-26 |
| 2025-09-30 | $28.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $149.00M derived: sum of 2 quarters · filed 2026-08-07 | $160.00M 10-Q · filed 2025-10-31 | $161.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $121.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $132.00M 10-Q · filed 2026-08-07 | $133.00M derived: sum of 3 quarters · filed 2026-08-07 | $133.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $11.00M 10-Q · filed 2026-05-01 | $12.00M derived: sum of 2 quarters · filed 2026-05-01 | $12.90M derived: sum of 3 quarters · filed 2026-05-01 | $13.90M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.90M derived: sum of 2 quarters · filed 2026-02-26 | $2.90M derived: sum of 3 quarters · filed 2026-02-26 | $18.90M 10-K · filed 2026-02-26 |
| 2024-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $1.90M derived: sum of 2 quarters · filed 2025-10-31 | $17.90M 10-Q · filed 2025-10-31 | $18.30M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $17.00M 10-Q · filed 2025-08-06 | $17.40M derived: sum of 3 quarters · filed 2026-02-26 | $23.40M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $16.00M 10-Q · filed 2025-05-01 | $16.40M derived: sum of 2 quarters · filed 2026-02-26 | $22.40M derived: sum of 3 quarters · filed 2026-02-26 | $23.20M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.40M derived: sum of 2 quarters · filed 2026-02-26 | $7.20M derived: sum of 3 quarters · filed 2026-02-26 | $7.40M 10-K · filed 2026-02-26 |
| 2023-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $6.80M derived: sum of 2 quarters · filed 2024-11-01 | $7.00M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.00M 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-02-27 | |||
| 2020-12-31 | $12.60M 10-K · filed 2023-02-27 | |||
| 2019-12-31 | $17.60M 10-K · filed 2022-02-25 | |||
| 2018-12-31 | $11.60M 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $4.20M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $100.00K 10-K · filed 2019-02-27 | |||
| 2015-12-31 | $200.00K 10-K · filed 2016-02-25 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $300.00K 10-K · filed 2016-02-25 | ||
| 2014-09-30 | $300.00K 10-Q · filed 2014-10-28 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $6.60M derived: sum of 2 quarters · filed 2016-02-25 | $16.90M 10-K · filed 2016-02-25 | |
| 2013-09-30 | $6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $16.90M 10-Q · filed 2014-10-28 | ||
| 2013-06-30 | $10.30M 10-Q · filed 2013-07-30 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $100.00K derived: sum of 2 quarters · filed 2015-03-02 | $300.00K 10-K · filed 2015-03-02 | |
| 2012-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $300.00K 10-Q · filed 2013-10-29 | ||
| 2012-06-30 | $200.00K 10-Q · filed 2013-07-30 | |||
| 2011-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $600.00K derived: sum of 2 quarters · filed 2014-02-20 | $900.00K derived: sum of 3 quarters · filed 2014-02-20 | $1.20M 10-K · filed 2014-02-20 |
| 2011-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $400.00K derived: sum of 2 quarters · filed 2011-11-04 | $700.00K 10-Q · filed 2011-11-04 | $700.00K derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $600.00K 10-Q · filed 2011-08-04 | $600.00K derived: sum of 3 quarters · filed 2013-02-19 | $1.00M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $300.00K 10-Q · filed 2011-05-02 | $300.00K derived: sum of 2 quarters · filed 2013-02-19 | $700.00K derived: sum of 3 quarters · filed 2013-02-19 | $7.30M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $400.00K derived: sum of 2 quarters · filed 2013-02-19 | $7.00M derived: sum of 3 quarters · filed 2013-02-19 | $10.40M 10-K · filed 2013-02-19 |
| 2010-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $7.00M derived: sum of 2 quarters · filed 2011-11-04 | $10.40M 10-Q · filed 2011-11-04 | $13.50M derived: sum of 4 quarters · filed 2012-09-06 |
| 2010-06-30 | $6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $10.00M 10-Q · filed 2011-08-04 | $13.10M derived: sum of 3 quarters · filed 2012-09-06 | $13.40M derived: sum of 4 quarters · filed 2012-09-06 |
| 2010-03-31 | $3.40M 10-Q · filed 2011-05-02 | $6.50M derived: sum of 2 quarters · filed 2012-09-06 | $6.80M derived: sum of 3 quarters · filed 2012-09-06 | |
| 2009-12-31 | $3.10M derived: 8-K 12 month − 10-Q 9 month · filed 2012-09-06 | $3.40M derived: sum of 2 quarters · filed 2012-09-06 | $5.00M 8-K · filed 2012-09-06 | |
| 2009-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-03 | $1.90M 10-Q · filed 2010-11-03 | ||
| 2009-06-30 | $1.60M 10-Q · filed 2010-08-05 | |||
| 2008-12-31 | $12.40M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |